MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 112.95% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 103.84% | -- | -- | -- | |
| Operating Income | -103.84% | -- | -- | -- | |
| Income Before Tax | -107.72% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -107.72% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -107.72% | -- | -- | -- | |
| EBIT | -103.84% | -- | -- | -- | |
| EBITDA | -104.88% | -- | -- | -- | |
| EPS Basic | -2.36% | -- | -- | -- | |
| Normalized Basic EPS | -1.59% | -- | -- | -- | |
| EPS Diluted | -2.36% | -- | -- | -- | |
| Normalized Diluted EPS | -1.59% | -- | -- | -- | |
| Average Basic Shares Outstanding | 1,070.52% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 1,070.52% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |